In one paragraphArticle in Biosensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Usanee WattananandkulDivision of Clinical Microbiology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-6648-8972 Sukanya SaikaewDivision of Clinical Microbiology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-0829-3413 Sirikwan SangboonruangDivision of Clinical Microbiology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0003-4987-5505 Rodjana PongsararukOffice of Disease Prevention and Control Region 1 (ODPC-1) Chiang Mai, Department of Disease Control, The Ministry of Public Health, Muang District, Chiang Mai 50100, Thailand.
Prapaporn SrilohasinDepartment of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.ORCID 0000-0003-4882-516X Bordin Butr-IndrDivision of Clinical Microbiology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-8560-6540 Sorasak IntorasootDivision of Clinical Microbiology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-7137-4750 Chayada Sitthidet TharinjaroenDivision of Clinical Microbiology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-1441-9641 Natthawat SemakulDepartment of Chemistry, Faculty of Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0003-2078-3201 Surachet ArunothongOffice of Disease Prevention and Control Region 1 (ODPC-1) Chiang Mai, Department of Disease Control, The Ministry of Public Health, Muang District, Chiang Mai 50100, Thailand.
Angkana ChaiprasertDrug Resistant Tuberculosis Research (DR-TB) Fund, Siriraj Foundation, Bangkok 10700, Thailand.
Khajornsak TragoolpuaDivision of Clinical Microbiology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0001-8812-5139 Funding
Chiang Mai University 207555Thailand Science Research and Innovation FRB680102/0162
6 · The paper itselfAbstract
Drug-resistant tuberculosis remains a major challenge to tuberculosis control, particularly in settings with limited access to conventional molecular testing. This study developed and preliminarily evaluated RR-TB GoldDx and Hr-TB GoldDx, rapid visual assays for detecting rifampicin- and isoniazid-resistance-associated mutations in
Indexed as
Biosensing TechniquesMetal NanoparticlesMycobacterium tuberculosisDrug Resistance, BacterialGoldHumansIsoniazidMutationRapid Diagnostic TestsRifampinGoldIsoniazidRifampinantimicrobial resistancedrug-resistant tuberculosisgold nanoparticlesmolecular diagnosticspoint-of-care testingrecombinase polymerase amplificationresource-limited settings
Identifiers
PMID42783173
PMCPMC13604076
What Socratic holds
Textmetadata
Read underepoch 390